Neural control mechanisms and vasovagal syncope.

J Cardiovasc Electrophysiol

Department of Medicine, University of Iowa, Iowa City 52242.

Published: October 1993

Patients with recurrent unexplained syncope may have cardioinhibitory and vasodepressor responses provokable with head-up tilt with or without exogenous beta-adrenergic stimulation. Although these responses are believed to be neurally mediated, the neural mechanisms involved are poorly understood. Numerous studies have documented peripheral vasodilation, hypotension, and bradycardia at the time of syncope and several case reports have shown sudden withdrawal of vasoconstrictor sympathetic neural outflow to skeletal muscle in human subjects. In cats and rats, a similar response can be provoked with hemorrhage and is prevented by interruption of cardiac vagal C-fiber afferents. In dogs, however, section of these fibers does not prevent the development of a vasodepressor response. The provocation of vasodepressor syncope during nitroprusside infusion in a heart transplant recipient with presumed ventricular denervation also suggests that cardiac afferent nerves may not be required for the development of vasodepressor responses in humans. Other potential mechanisms include release of endogenous opioids or nitric oxide that may inhibit sympathetic nerve firing, and primary central nervous system activation (as in partial seizures) that triggers cardioinhibitory and vasodepressor responses. This article reviews our current understanding of the mechanisms involved in the development of neurally mediated syncope.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8167.1993.tb01246.xDOI Listing

Publication Analysis

Top Keywords

vasodepressor responses
12
cardioinhibitory vasodepressor
8
neurally mediated
8
mechanisms involved
8
development vasodepressor
8
syncope
5
vasodepressor
5
neural control
4
mechanisms
4
control mechanisms
4

Similar Publications

Background: Syncope is a common medical condition. The reflex or neurally mediated syncope (NMS) is the most frequent type. The tilt table test (TTT) helps distinguish syncope from other common causes of complete loss of consciousness, such as epilepsy, define syncope subtypes and guide management.

View Article and Find Full Text PDF
Article Synopsis
  • Head-up tilt testing (HUT) is a procedure used to evaluate patients with syncope (fainting) to determine if there's a reflex cause, but existing protocols can be lengthy and vary in effectiveness.
  • This study focused on carotid sinus massage (CSM) as a potential quick predictor of HUT outcomes, involving 50 patients who underwent tests both before and after HUT.
  • The results showed that CSM had a high sensitivity (88.24%) and specificity (100%) in identifying patients who would test positive on the tilt table, suggesting that CSM could simplify the testing process.
View Article and Find Full Text PDF

Prevalence and clinical predictors of vasodepressor syncope during head up tilt test.

Eur J Intern Med

December 2024

IRCCS Istituto Auxologico Italiano, Faint and Fall Research Centre, Department of Cardiology, S. Luca Hospital, Milan, Italy.

Article Synopsis
  • The study aimed to assess how common vasodepressor (VD) responses are during head-up tilt tests (HUTT) in patients with a history of fainting (syncope) over a six-year period.
  • Out of 1,780 patients, 7% exhibited a VD response, with higher rates observed in males and those over 69 years old.
  • Age was found to be the only significant predictor of VD response, while factors like smoking and atypical fainting presentations reduced the likelihood of this response.
View Article and Find Full Text PDF
Article Synopsis
  • Cisplatin (CDDP) is an effective chemotherapy drug, but its use is limited by kidney damage (nephrotoxicity), which may be linked to the renin-angiotensin system (RAS).
  • A systematic review analyzed the relationship between CDDP and RAS by examining nine studies, revealing that RAS activation contributes to kidney damage through inflammatory responses and tissue damage markers.
  • The review highlights important gender differences: while inhibiting the RAS can reduce kidney damage in males, it may worsen nephrotoxicity in females, pointing to the need for tailored treatments.
View Article and Find Full Text PDF

Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats.

Pharmaceuticals (Basel)

December 2023

Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Deleg. Tlalpan, Ciudad de México 14330, Mexico.

Purine nucleosides (adenosine) and nucleotides such as adenosine mono/di/triphosphate (AMP/ADP/ATP) may produce complex cardiovascular responses. For example, adenosine-5'-(β-thio)-diphosphate (ADPβS; a stable synthetic analogue of ADP) can induce vasodilatation/vasodepressor responses by endothelium-dependent and independent mechanisms involving purinergic P2Y receptors; however, the specific subtypes participating in these responses remain unknown. Therefore, this study investigated the receptor subtypes mediating the blood pressure changes induced by intravenous bolus of ADPβS in male Wistar rats in the absence and presence of central mechanisms with the antagonists MRS2500 (P2Y), PSB0739 (P2Y), and MRS2211 (P2Y).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!